Indivior PLC (LON:INDV - Get Free Report)'s share price traded up 9.9% during mid-day trading on Monday . The stock traded as high as GBX 1,090 ($14.88) and last traded at GBX 1,084 ($14.80). 496,685 shares traded hands during mid-day trading, a decline of 39% from the average session volume of 808,406 shares. The stock had previously closed at GBX 986 ($13.46).
Indivior Trading Up 4.8%
The business's fifty day moving average is GBX 922.58 and its 200-day moving average is GBX 859.45. The company has a debt-to-equity ratio of -170.06, a quick ratio of 1.52 and a current ratio of 0.83. The firm has a market cap of £1.75 billion, a P/E ratio of -928.64, a price-to-earnings-growth ratio of -5.57 and a beta of 0.19.
Insider Activity at Indivior
In other Indivior news, insider Juliet Thompson acquired 3,850 shares of Indivior stock in a transaction that occurred on Wednesday, June 11th. The shares were bought at an average price of GBX 1,388 ($18.95) per share, with a total value of £53,438 ($72,972.83). Company insiders own 3.44% of the company's stock.
Indivior Company Profile
(
Get Free Report)
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Featured Articles
Before you consider Indivior, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Indivior wasn't on the list.
While Indivior currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
